PROCEPT BioRobotics Corp
Closed
SectorHealthcare
20.28 2.68
Overview
Share price change
24h
Min
19.67
Max
21.21
Income | -1.8M -32M |
|---|---|
Sales | 6.7M 83M |
EPS | -0.56 |
Profit margin | -38.058 |
Employees | 888 |
EBITDA | -7.3M -29M |
Recommendations | Neutral |
|---|---|
12 Months Forecast | +15.48% upside |
Next Earnings | 3 Nov 2026 |
|---|
Market Cap | -325M 1B |
|---|---|
Previous open | 17.6 |
Previous close | 20.28 |
PROCEPT BioRobotics Corp Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
PROCEPT BioRobotics Corp Forecast
Price Target
By TipRanks
15.48% upside
12 Months Forecast
Average 23.13 USD 15.48%
High 29 USD
Low 19 USD
Based on 11 Wall Street analysts offering 12 month price targets forPROCEPT BioRobotics Corp - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About PROCEPT BioRobotics Corp
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.